Henoch-Schonlein Purpura Complicated by Cardiac Involvement: Case Report and Review of the Literature

被引:14
作者
Lutz, Holger H. [2 ]
Ackermann, Thomas
Krombach, Gabriele A. [3 ]
Groene, Hermann-Josef [4 ]
Rauen, Thomas [5 ]
Floege, Juergen [5 ]
Mertens, Peter R. [1 ,5 ]
机构
[1] Otto VonGuericke Univ Magdegurg, Dept Hypertens & Nephrol, D-39120 Magdeburg, Germany
[2] Univ Hosp RWTH Aachen, Dept Gastroenterol & Hepatol, Aachen, Germany
[3] Univ Hosp RWTH Aachen, Dept Diagnost Radiol, Aachen, Germany
[4] German Canc Res Ctr, Dept Cellular & Mol Pathol, Heidelberg, Germany
[5] Univ Hosp RWTH Aachen, Dept Nephrol & Clin Immunol, Aachen, Germany
关键词
Henoch-Schonlein purpura; immunoglobulin A (IgA) nephropathy; focal segmental glomerulosclerosis; microangiopathy; cyclophosphamide; IGA NEPHROPATHY; NEPHRITIS; MANIFESTATIONS; VASCULITIS; THERAPY; TRIAL;
D O I
10.1053/j.ajkd.2009.04.017
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Involvement of the kidneys in Henoch-Schonlein purpura (HSP) occurs in approximately 50% of patients with HSP, with varying severity. In general, disease outcome is favorable for adolescents. However, severe courses with vasculitis impairing multiple organ systems in addition to the kidney, including brain, heart, and intestine, may occur. This involvement, often manifesting more subtly, requires alertness for diagnosis and escalation of immunosuppressive therapy for treatment. We report a case of severe HSP nephritis with cardiac involvement in a young man. Cardiac involvement was noted initially on an electrocardiogram and Visualized by using cardiac magnetic resonance imaging. HSP remission was induced with aggressive cytotoxic therapy, consisting of cyclophosphamide (750 mg/m(2) every 4 weeks) in addition to high-dose prednisolone. The case presentation is followed by a review of the literature for manifestations, treatments, and outcomes in patients with HSP complicated by cardiac involvement. Am J Kidney Dis 54:e9-e15. (C) 2009 by the National Kidney Foundation, Inc.
引用
收藏
页码:E9 / E15
页数:7
相关论文
共 25 条
[1]   MYOCARDIAL-INFARCTION - A RARE COMPLICATION IN HENOCH-SCHONLEIN PURPURA [J].
ABDELHADI, O ;
HARTLEY, RB ;
GREENSTONE, MA ;
KIDNER, PH .
POSTGRADUATE MEDICAL JOURNAL, 1981, 57 (668) :390-392
[2]   Cardiopulmonary manifestations of Henoch-Schonlein Purpura [J].
Agraharkar, M ;
Gokhale, S ;
Le, L ;
Rajaraman, S ;
Campbell, GA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (02) :319-322
[3]  
Ballardie FW, 2002, J AM SOC NEPHROL, V13, P142, DOI 10.1681/ASN.V131142
[4]  
Çakir N, 2004, CLIN EXP RHEUMATOL, V22, P235
[5]   A fatal case of bowel and cardiac involvement in Henoch-Schonlein purpura [J].
Carmichael, P ;
Brun, E ;
Jayawardene, S ;
Abdulkadir, A ;
O'Donnell, PJ .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (03) :497-499
[6]  
Floege J, 2000, J AM SOC NEPHROL, V11, P2395, DOI 10.1681/ASN.V11122395
[7]   Immune modulating therapy for IgA nephropathy: Rationale and evidence [J].
Floege, Juergen ;
Eitner, Frank .
SEMINARS IN NEPHROLOGY, 2008, 28 (01) :38-47
[8]  
FOGAZZI GB, 1989, CLIN NEPHROL, V31, P60
[9]   A case of Henoch-Schonlein purpura and rheumatic carditis with complete atrioventricular block [J].
Güven, H ;
Özhan, B ;
Bakiler, AR ;
Salar, K ;
Kozan, M ;
Bilgin, S .
EUROPEAN JOURNAL OF PEDIATRICS, 2006, 165 (06) :395-397
[10]   Henoch-Schonlein purpura: a case with atypical presentation [J].
Kalyoncu, M ;
Cakir, M ;
Erduran, E ;
Okten, A .
RHEUMATOLOGY INTERNATIONAL, 2006, 26 (07) :669-671